Pharmaceuticals - Slovenia

Slovenia

In 2024, the revenue in the Pharmaceuticals market in Slovenia is projected to reach US$459.20m.
The largest market within the pharmaceuticals industry is Oncology Drugs, with a projected market volume of US$87.90m in 2024.
It is expected that the revenue will show an annual growth rate (CAGR 2024-2028) of 6.00%, resulting in a market volume of US$579.70m by 2028.
When compared globally, United States is expected to generate the most revenue in the Pharmaceuticals market, reaching US$636.90bn in 2024.
Slovenia's pharmaceutical market is experiencing a surge in demand for innovative and personalized medicines.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Slovenia has been growing steadily in recent years, driven by several factors that are unique to the country.

Customer preferences: Slovenian customers are increasingly demanding high-quality pharmaceutical products that are safe and effective. This trend is driven by the growing awareness of health and wellness among the population, as well as the increasing availability of information about the benefits of different types of drugs. Customers in Slovenia also tend to prefer products that are affordable and accessible, which has led to the growth of generic drug manufacturers in the country.

Trends in the market: One of the key trends in the Slovenian Pharmaceuticals market is the growing demand for innovative drugs that can address specific health issues. This trend is driven by the aging population in the country, which is leading to an increase in chronic diseases and other health problems. As a result, pharmaceutical companies are investing in research and development to create new drugs that can meet the needs of this growing segment of the population. Another trend in the market is the increasing use of digital technologies to improve the delivery of pharmaceutical products and services. This includes the use of telemedicine, online pharmacies, and other digital tools that can help patients access the care they need more easily and efficiently.

Local special circumstances: Slovenia has a relatively small pharmaceutical market compared to other countries in the region, which has led to a higher level of competition among manufacturers. This has also led to a focus on developing niche products that can meet the specific needs of the local population. Additionally, the country has a well-developed healthcare system that provides universal access to medical care, which has helped to drive demand for pharmaceutical products.

Underlying macroeconomic factors: The Slovenian economy has been growing steadily in recent years, which has helped to support the growth of the Pharmaceuticals market. Additionally, the country has a well-educated and skilled workforce, which has helped to attract investment from pharmaceutical companies. The government has also implemented policies to support the development of the industry, including tax incentives and other measures to encourage research and development. However, the market is also subject to regulatory challenges, including strict pricing controls and a complex approval process for new drugs. Despite these challenges, the outlook for the Slovenian Pharmaceuticals market remains positive, driven by the growing demand for innovative products and the government's commitment to supporting the industry.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.